scholarly journals Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

Hepatology ◽  
1998 ◽  
Vol 27 (4) ◽  
pp. 1121-1127 ◽  
Author(s):  
Geoffrey C. Farrell ◽  
Bruce R. Bacon ◽  
Robert D. Goldin ◽  
Sign in / Sign up

Export Citation Format

Share Document